Cargando…

Induction of type II collagen-reactive IL-10-producing CD11b(+ )dendritic cells in Payer's patch of orally tolerized animals

Detalles Bibliográficos
Autores principales:	Kim, H, So-Youn, M, Mi-La, C, Jung-Eun, L, Sung-Hwan, P, Kang-Eun, L, Kyung-Soo, P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833895/ http://dx.doi.org/10.1186/ar905

Ejemplares similares

Induction of IL-10-producing CD4(+)CD25(+ )T cells in animal model of collagen-induced arthritis by oral administration of type II collagen
por: Min, So-Youn, et al.
Publicado: (2004)

Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4(+)CD25(+ )regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model
por: Park, Min-Jung, et al.
Publicado: (2008)

Role of Dendritic Cells in the Induction of Lymphocyte Tolerance
por: Osorio, Fabiola, et al.
Publicado: (2015)

Mechanisms of Tolerance Induction by Dendritic Cells In Vivo
por: Hasegawa, Hitoshi, et al.
Publicado: (2018)

Manipulation of Regulatory Dendritic Cells for Induction Transplantation Tolerance
por: Que, Weitao, et al.
Publicado: (2020)

Hospitals and the Tax-Payer
Publicado: (1920)

Are payers treating orphan drugs differently?
por: Cohen, Joshua P., et al.
Publicado: (2014)

The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells
por: Steinman, Ralph M., et al.
Publicado: (2000)

Therapeutic Potential of Semi-Mature Dendritic Cells for Tolerance Induction
por: Lutz, Manfred B.
Publicado: (2012)

Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine
por: Manni, Giorgia, et al.
Publicado: (2020)

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
por: Fucikova, Jitka, et al.
Publicado: (2019)

A Private Payer Persective
por: Shurney, Dexter W.
Publicado: (2006)

Preferential induction of polyclonal IgA secretion by murine Peyer's patch dendritic cell-T cell mixtures
Publicado: (1984)

Properties of collagen-based hemostatic patch compared to oxidized cellulose-based patch
por: Slezak, Paul, et al.
Publicado: (2018)

Interferon Gamma Suppresses Collagen-Induced Arthritis by Regulation of Th17 through the Induction of Indoleamine-2,3-Deoxygenase
por: Lee, Jaeseon, et al.
Publicado: (2013)

In situ induction of dendritic cell–based T cell tolerance in humanized mice and nonhuman primates
por: Jung, Kyeong Cheon, et al.
Publicado: (2011)

IL-22 gene transfer in collagen-induced arthritis
por: Apparailly, F, et al.
Publicado: (2004)

In vivo induction of foxp3 in collagen-induced arthritis treatment with modified dendritic cells
por: Falgarone, G, et al.
Publicado: (2005)

Interferon-α Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells
por: Bacher, Nicole, et al.
Publicado: (2011)

Experimental study of the mechanism of tolerance induction in dexamethasone-treated dendritic cells
por: Gong, Yu-bo, et al.
Publicado: (2011)

Tolerogenic dendritic cells in experimental autoimmune encephalomyelitis, specific tolerance induction?
por: Sellés-Moreno, Carla, et al.
Publicado: (2012)

Molecular Mechanisms of Induction of Tolerant and Tolerogenic Intestinal Dendritic Cells in Mice
por: Steimle, Alex, et al.
Publicado: (2016)

Correction: In situ induction of dendritic cell–based T cell tolerance in humanized mice and nonhuman primates
por: Jung, Kyeong Cheon, et al.
Publicado: (2016)

All-payer ratesetting: Down but not out
por: Anderson, Gerard F.
Publicado: (1992)

Payer-Negotiated Prices for Telemedicine Services
por: Wu, Shannon S., et al.
Publicado: (2022)

An integrated valuation model for payer and investor
por: Nuijten, Mark, et al.
Publicado: (2022)

Payer Perspectives on Health Technology Assessment
por: Watkins, John B.
Publicado: (2012)

Induction of Donor-Specific Tolerance: Is This Achievable?
por: Cho, Eun Jin, et al.
Publicado: (2012)

Preparation and Evaluation of Collagen-Based Patches as Curcumin Carriers
por: Terzopoulou, Zoi, et al.
Publicado: (2020)

Variation in Private Payer Coverage of Rheumatoid Arthritis Drugs
por: Chambers, James D., et al.
Publicado: (2016)

Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance
por: Lin, Guojiao, et al.
Publicado: (2023)

Generation of IL-23 Producing Dendritic Cells (DCs) by Airborne Fungi Regulates Fungal Pathogenicity via the Induction of T(H)-17 Responses
por: Chamilos, Georgios, et al.
Publicado: (2010)

Variability in Private Payer Medical Policies for Osteochondral Allograft Transplantation Demonstrates the Absence of Standardization in Medical Criteria Between Payers
por: Tabbaa, Suzanne M., et al.
Publicado: (2022)

Managed care and inpatient mortality in adults: effect of primary payer
por: Hines, Anika L., et al.
Publicado: (2017)

Benchmarking HIV Quality Measures Across US Payer Types
por: Priest, Julie L., et al.
Publicado: (2020)

Assessing payer perspectives on health information exchange
por: Cross, Dori A, et al.
Publicado: (2016)

Patient and Payer Preferences for Additional Value Criteria
por: Jakab, Ivett, et al.
Publicado: (2021)

Pharmaceutical Technology Assessment: Perspectives from Payers
por: Leung, Musetta Y., et al.
Publicado: (2012)

IL-17-deficient allogeneic bone marrow transplantation prevents the induction of collagen-induced arthritis in DBA/1J mice
por: Park, Min-Jung, et al.
Publicado: (2012)

Cysteine-Reactive Free ISG15 Generates IL-1β–Producing CD8α(+) Dendritic Cells at the Site of Infection
por: Napolitano, Anna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8161b82m3s99futr7n0hetk4na